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ABSTRACT
Skeletal myogenesis serves as a paradigm to investigate the
molecular mechanisms underlying exquisitely regulated cell fate
decisions in developing embryos. The evolutionarily conserved miR-
133 family of microRNAs is expressed in the myogenic lineage, but
how it acts remains incompletely understood. Here, we performed
genome-wide differential transcriptomics of miR-133 knockdown
(KD) embryonic somites, the source of vertebrate skeletal muscle.
These analyses, performed in chick embryos, revealed extensive
downregulation of Sonic hedgehog (Shh) pathway components:
patched receptors, Hedgehog interacting protein and the
transcriptional activator Gli1. By contrast, Gli3, a transcriptional
repressor, was de-repressed and confirmed as a direct miR-133
target. Phenotypically, miR-133 KD impaired myotome formation and
growth by disrupting proliferation, extracellular matrix deposition and
epithelialization. Together, these observations suggest that miR-133-
mediated Gli3 silencing is crucial for embryonic myogenesis.
Consistent with this idea, we found that activation of Shh signalling
by either purmorphamine, or KD of Gli3 by antisense morpholino,
rescued the miR-133 KD phenotype. Thus, we identify a novel Shh/
myogenic regulatory factor/miR-133/Gli3 axis that connects epithelial
morphogenesis with myogenic fate specification.
KEY WORDS: miR-133, Chick embryo, Somite myogenesis,
Sonic hedgehog signalling, Gli3, Basement membrane
INTRODUCTION
Skeletal muscle is important for mobility and survival. Its
development is a highly regulated process, involving developmental
signals and their effector pathways, a hierarchy of transcription
factors – the myogenic regulatory factors (MRFs), and post-
transcriptional regulation by noncoding RNAs (Buckingham and
Rigby, 2014; Mok and Sweetman, 2011).
In vertebrate embryos, skeletal muscles of the trunk and limbs are
derived from somites, transient paired segments that form in a regular
sequence on either side of the neural tube and notochord (Christ and
Scaal, 2008). In response to signals, including Wnt, Shh and Notch
(Abou-Elhamd et al., 2015; Abu-Elmagd et al., 2010; Borycki et al.,
1999; Johnson et al., 1994; Münsterberg et al., 1995; Rios et al.,
2011; Sieiro et al., 2016), the initially epithelial somite undergoes
morphogenetic changes and differentiates. On the ventral side, cells
dissociate to form the sclerotome, whilst the dermomyotome on the
dorsal side remains epithelial and contributes myocyte progenitors
to the myotome. Myotome formation initiates at the epaxial lip of
the dermomyotome, abutting the neural tube (Gros et al., 2004).
Interactions with migrating neural crest cells triggers translocation
of dermomyotomal lip progenitors into the myotome, where they
orientate, elongate and begin to differentiate into myocytes (Rios
et al., 2011; Sieiro et al., 2016).
Shh, derived from the notochord and floor plate, activates
myogenesis (Münsterberg et al., 1995), and is essential for the
activation of the myogenic determination gene, Myf5, in epaxial
muscle progenitor cells in mice (Borycki et al., 1999; Gustafsson
et al., 2002), or in both epaxial and hypaxial domains in avian
embryos (Kahane et al., 2013). Myf5 activation is mediated via Gli
activator proteins, Gli1 and Gli2, acting on a Gli-binding site in the
mouse epaxial enhancer (Gustafsson et al., 2002; McDermott et al.,
2005; Teboul et al., 2002). In the absence of Shh, the Gli3 repressor
inhibits Myf5 transcription (McDermott et al., 2005). Furthermore,
in both avian and mouse embryos, Shh signalling is crucial for the
transition from proliferating Pax7-positive progenitors to terminally
differentiating myocytes (Kahane et al., 2013).
MicroRNAs (miRNAs or miRs) are short noncoding RNAs that
bind to target sites located in 3′UTRs of mRNAs. This interaction
leads to inhibition of translation, mRNA cleavage and transcript
degradation via deadenylation (Bartel, 2009; Béthune et al., 2012).
Through their effects on target gene expression, miRNAs regulate
developmental timing and provide robustness to cell fate decisions
(Ebert and Sharp, 2012; Hornstein and Shomron, 2006). The miR-1,
miR-206 and miR-133 families, comprising miR-1-1/2, miR-206
and miR-133a/b, are encoded by three loci in mouse and human,
and by four loci in chicken (Sweetman et al., 2008). One member of
each family is produced from the same primary transcripts and they
play important roles in regulating proliferation, differentiation and
cell fate specification in developing muscle (Horak et al., 2016;Mok
et al., 2017). In mouse and chicken embryos, miR-1/miR-133a are
expressed in skeletal and cardiac muscle. By contrast, miR-206/
miR-133b are expressed in myoblasts of somites, limb buds and
head muscles, but not in cardiomyocytes (Darnell et al., 2006;
Sweetman et al., 2008). In Xenopus and zebrafish, the miR-1, miR-
206 and miR-133 families are present in skeletal muscle but are not
detected in the heart (Ahmed et al., 2015; Mishima et al., 2009).
Together with myocyte enhancer factor-2 (MEF2) proteins, the
MRFs regulate expression of miR-1, miR-206 and miR-133 in
somites (Liu et al., 2007; Sweetman et al., 2008) and in C2C12Received 19 September 2017; Accepted 10 May 2018
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myoblasts (Rao et al., 2006; Rosenberg et al., 2006). In C2C12
myoblasts, the miR-1, miR-206 and miR-133 families regulate the
balance between differentiation and proliferation through
interactions with multiple targets (Alteri et al., 2013; Chen et al.,
2006; Feng et al., 2013; Goljanek-Whysall et al., 2012).
We previously used miRNA knockdown (KD) in chick somites
to show that miR-1, miR-206 and miR-133 negatively regulate BRG1/
BRM-associated factor 60 (BAF60) variants BAF60A and BAF60B.
This facilitates the preferential incorporation of BAF60C into the
BAF protein/BRG1 chromatin remodelling complex required for
myogenesis (Goljanek-Whysall et al., 2014). In earlier somites, miR-
206 facilitates the complete downregulation of Pax3 in the myotome,
ensuring timely transition of myogenic progenitor to committed
myoblast (Goljanek-Whysall et al., 2011). Studies in mice showed that
miR-133a isoforms are essential for themaintenance of skeletal muscle
structure and myofibre identity (Liu et al., 2011), and for controlling
brown fat differentiation through targeting Prdm16 (Trajkovski et al.,
2012); although deletion of the miR-206/133b cluster did not result
in skeletal muscle defects (Boettger et al., 2014). In zebrafish,
transcriptomic analysis revealed the importance ofmiR-1 andmiR-133
for sarcomeric actin organization (Mishima et al., 2009). However, the
functions of miR-133 in early myogenesis remain unclear.
Here, we characterize the mechanisms that underlie the embryonic
phenotype resulting from antagomir-mediated miR-133 KD in avian
somites. Impaired myogenesis was evident from reduced expression of
MRFs, reduced cell proliferation and impaired growth of the
dermomyotome and myotome, as well as reduced actin accumulation
and disorganized basement membrane (BM) deposition. Differential
transcriptomics of miR-133 KD somites identified negative effects on
Shh pathway components, suggesting a role for miR-133 in
modulating Shh signalling. Expression of the Gli3 transcriptional
repressor was de-repressed after miR-133 KD, and luciferase assays
confirmed direct regulation via a functional target site in the Gli3 3′
UTR that is complementary to the miR-133 seed sequence. Myotome
formation and epithelialization, BM deposition and myogenic
differentiation were restored in miR-133 KD somites by concomitant
activation of Shh signalling using purmorphamine, a synthetic agonist
of the smoothened (Smo) receptor (Sinha and Chen, 2006), or by the
concomitant morpholino (MO)-mediated knockdown of Gli3
repressor. Our data identify a novel Shh/MRF/miR-133/Gli3 axis
and show that stabilization of myogenic differentiation and growth of
the myotome require the negative regulation of Gli3 by miR-133.
RESULTS
miR-133 is expressed in nascent myoblasts
The spatiotemporal expression of miR-133 was determined by
whole-mount in situ hybridization. In Hamburger Hamilton (HH)
stage 15 chick embryos (Hamburger and Hamilton, 1951), miR-133
was detected in early stage somites (sIII/IV) and in differentiating
somites. Expression was also seen in the neural tube, brain, anterior
notochord, mesonephric duct and heart (Fig. S1A). In early somites,
which begin to de-epithelialize ventrally, expression was detected
adjacent to the neural tube, where the first myoblasts emerge. The
relative expression levels of miR-133 increased as somites matured,
and in differentiating somites miR-133 was restricted to the myotome
(Fig. S1A,B), as previously reported for older-stage embryos
(Goljanek-Whysall et al., 2011; Sweetman et al., 2008).
miR-133 coordinates cell fate acquisition with somite
morphogenesis
Somites are severely affected by antagomir-mediated KD of
miR-133, with epithelial morphology lost in the dermomyotome
and myotome, and myogenin (Mgn) expression either lost
completely (80%) or partially (20%), indicating that by 24 h,
myogenesis is compromised (Figs 1B and 4B) (Goljanek-Whysall
et al., 2014).
To characterize in more detail the underlying cellular and
molecular mechanisms, we established that effects resulting from
miR-133 inhibition were first detected after 9 h. Epithelial somites
of HH14/15 embryos injected with fluorescein isothiocyanate
(FITC)-labelled antagomir-133 (AM133) and examined after 6, 9,
12 or 24 h (Fig. 1A) showed partial loss ofMyf5,MyoD (Fig. S2A)
andMgn expression 9 h after miR-133 KD (Fig. 1B). No phenotype
was detected after 6 h, and after 12 and 24 h, phenotypes were more
pronounced (Fig. 1B, Fig. S2B). Control injections of scrambled
Fig. 1. Inhibition of miR-133 leads to a myogenic phenotype.
(A) Schematic overview of the experimental approach. Posterior somites of
HH14/15 embryos were injected with FITC-labelled antagomir-133 (AM133)
and the downstream analysis was performed by in situ hybridization.
(B) Embryos were incubated for 6, 9, 12 and 24 h after AM133 injection as
indicated. In situ hybridization detects transcripts for myogenin (Mgn, purple)
and AM133 is shown in red. After 6 h, there is no change in Mgn expression
in injected somites (white asterisks, n=7/8). After 9 h, the most posterior
somites show a loss of (white arrowheads) or reduced (black arrowheads)
Mgn expression (n=12/16). The negative effect on myogenic differentiation
becomes more pronounced after 12 h and 24 h (n=8/8, n=14/14).
(C) RT-qPCR for miR-133 of somites, pooled from aminimum of four embryos,
injected with AM133 compared with contralateral noninjected somites,
harvested after 6, 9, 12 or 24 h of incubation as indicated. ***P<0.001;
**P=0.001-0.01; NS, not significant.
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antagomir (AMscr) had no effect (Fig. S3A-D). Reverse
transcription quantitative polymerase chain reaction (RT-qPCR)
confirmed significantly reduced abundance of miR-133 in somites
after AM133 injection (Fig. 1C), also observed with northern blot
analysis (Goljanek-Whysall et al., 2014). Interestingly, AM133
injections of the equivalent, interlimb-level somites at later stages
(HH20), when miR-133 is expressed in a more developedmyotome,
did not lead to myogenic defects (Fig. S2C), suggesting a critical
window in younger, less mature somites, in which miR-133
function is essential.
Pax3 and Pax7 immunostaining of cryosections revealed a
reduced dermomyotome size, confirmed by pixel measurements
using Fiji/ImageJ, in AM133-injected somites compared with
somites from the contralateral noninjected side (HH14/15)
(Fig. 2A,B). Phosphor histone H3 (pH3) staining showed fewer
mitotic cells present in the dermomyotome and myotome,
indicating impaired cell proliferation after miR-133 KD (Fig. 2C).
Immunostaining for caspase-3 (Cas3) showed no detectable
increase in apoptotic cells (Fig. S2D). AMscr injections did not
affect dermomyotome proliferation or size (Fig. S3A-C).
Epithelial organization of the dermomyotome, assessed by actin
staining, showed a reduced number of apicobasal-orientated
dermomyotomal cells. Furthermore, the dermomyotomal lip was
poorly defined, had lost its epithelial character and had less actin
accumulated than in the same structure in noninjected somites
(Fig. 2D). In addition, discontinuous and disorganized laminin
staining suggested that BM deposition was impaired, and a BM had
not fully formed on the basal side of dermomyotome cells or
beneath the myotome (Fig. 2D). The BM surrounding the neural
tube remained unaffected, and AMscr injections did not affect
epithelial organization of the dermomyotome (Fig. S3D).
Inhibition of miR-133 affects Shh pathway components
The discrete molecular and cellular changes observed after 9 h in
the dermomyotome and myotome following AM133 injection
culminate in severe impairment of myogenesis by 24 h
(Figs 1 and 2, Figs S2 and S3). Genome-wide differential
transcriptomics of AM133- or AMscr-injected somites was used
to identify the pathways and cellular processes involved (Fig. 3,
Fig. S4). This was performed at 9 h to capture the earliest events.
Hierarchical clustering confirmed that AM133-injected somites
were more similar to each other than to control somites, and
identified differentially expressed (DE) genes (Fig. 3B). Gene
ontology (GO) analysis showed that the genes involved in
processes relating to cell division were significantly decreased
(Fig. 3C), consistent with observations that dermomyotome size
and number of mitotic cells were reduced after miR-133 KD.
Amongst the top 50 significantly downregulated DE genes were
myogenic markers, Myf5 and MyoD, and sclerotome markers,
Pax1 and Pax9. Strikingly, several Shh pathway components were
also in this group, including patched-1 (Ptch1) and patched-2
(Ptch2) receptors, Hedgehog interacting protein (Hhip) and the
transcriptional activator Gli1 (Fig. 3B,D). Thus, we looked for a
transcriptional repressor of Shh pathway genes amongst the genes
for which relative expression was increased. A strong candidate
was Gli3, which was amongst the top 200 de-repressed genes and
its expression was significantly increased (P=0.03) (Fig. 3D).
Gli3 was therefore a putative direct target gene for miR-133.
A miR-133 target site identified in its 3′UTR – conserved in
human, chimp, mouse, cow and frog – was validated by luciferase
reporter assays. Reporter gene expression was inhibited
significantly after transfection of miR-133. Introducing mutations
into the 8-mer seed sequence of the target site restored reporter
gene expression even in the presence of miR-133 (Fig. 3E),
confirming its importance. A control miRNA had no effect.
Furthermore, analysis of Gli3 protein levels by western blotting
confirmed a relative increase of the short repressor isoform
(Gli3Rep) in somites following miR-133 inhibition in vivo
using AM133 injection compared with control AMscr-injected
somites (Fig. 3F).
Fig. 2. Dermomyotome growth, epithelial organization and basement membrane deposition are disrupted after inhibition of miR-133.
(A) Schematic overview of the experimental approach. Posterior somites of HH14/15 embryos were injected with FITC-labelled antagomir-133 (AM133) and
the downstream analysis was performed by immunostaining after 9 h of incubation. (B) Immunostaining for Pax3, Pax7, AM133 and DAPI as indicated. The areas
positive for Pax3 or Pax7 within the somite were quantified using Fiji/ImageJ, and were significantly smaller in AM133-injected somites compared with somites
from the noninjected contralateral control side. Higher magnification images of injected somites showed disruption to dermomyotome morphology (white
arrowheads). (C) Immunostaining for pH3, AM133 and DAPI as indicated. The number of pH3-positive cells was significantly reduced in AM133-injected somites
(white arrowheads) compared with somites from the contralateral side. ***P<0.001. (D) Immunostaining for F-actin, laminin, AM133 and DAPI as indicated.
Higher magnification images of noninjected and injected somites stained for F-actin or laminin are shown on the right. White arrowheads indicate disorganized
and disrupted staining in the dermomyotome region. Scale bars: 50 μm.
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Shh pathway activation rescues miR-133 KD
The finding that Gli3, which acts predominantly as a transcriptional
repressor, is a direct target for miR-133 and de-repressed after
miR-133 KD (Fig. 3D,F), led us to test whether pharmacological
activation of the Shh pathway can rescue the myogenic phenotype.
Knockdown of miR-133 completely inhibited myogenesis after
24 h (Figs 1B and 4B, Fig. S2B). However, co-injection of AM133
and purmorphamine, an activator of Shh signalling (Fig. 4A),
restored myogenic differentiation, as shown by expression of Mgn
(Fig. 4B). To determine whether Gli3 de-repression was crucial for
the phenotype observed, we knocked down Gli3 expression using
MOs and examined whether this could rescue the AM133-induced
loss of Mgn. A FITC-labelled Gli3-translation-blocking MO was
electroporated concomitant with AM133 injection (Fig. 4C,D).
Western blots of transfected somites showed that Gli3Rep protein
was reduced by Gli3 MO compared with control MO (Fig. S3F).
A faint band representing the full-length Gli3 activator (Gli3Act)
was present in both samples, consistent with the finding that
Gli3Act becomes rapidly degraded (Wen et al., 2010). In situ
hybridization showed that Gli3 MO restored myogenesis in
AM133-treated somites (Fig. 4D), suggesting that miR-133
mediates its effects via negative regulation of Gli3.
Somite organization was improved after treatment with
purmorphamine or the concomitant transfection of Gli3 MO
Fig. 3. Differential transcriptomics reveals misregulation of Shh pathway components and identifies Gli3 as a direct miR-133 target. (A) Schematic
overview of the experimental approach. Posterior somites of HH14/15 embryoswere injected with FITC-labelled antagomir-133 (AM133) or scrambled-antagomir
(AMscr) and harvested after 9 h for RNA isolation and sequencing. (B) Heatmaps of the top 50 genes significantly downregulated or upregulated after miR-133 KD
shows clustering of six samples injected with AMscr or with AM133. (C) GO analysis showed that amongst the downregulated DE group, genes associated
with cell cycle processes were significantly over-represented. The false discovery rates (FDRs) are shown for these genes. (D) Table showing Hedgehog (Hh)
pathway genes that were de-repressed (yellow) and repressed (blue), including the transcriptional regulator Gli3, with log2 fold change and P-values.
(E) Conservation of miR-133 seed sequence pairing region within the Gli3 3′UTR of different species. Luciferase assays validate Gli3 as a direct target for
miR-133. Schematic of the chick Gli3 gene with a predicted target site containing an 8-mer seed match (red) present in the 3′UTR. Mutations (underlined)
introduced into the predicted target site were designed to disrupt base pairing with the miR-133 seed region. A modified pGL3 vector containing a 1070 bp
fragment of the chickGli3 3′UTR downstream of the firefly luciferase reporter gene. Transfection of reporter plasmids into DF1 cells either on their own (white), or
with a control miRNA mimic (black), or with miR-133 mimic (grey) confirms negative regulation of the reporter. The response was rescued after mutation of
the target site. ***P<0.001; NS, not significant. (F) Western blot of somites injected with AMscr or AM133 shows increased amount of Gli3Rep protein.
Quantitative analysis was performed on three biological replicates. *P<0.1; NS, not significant.
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together with AM133; however, the somites were smaller
(Fig. 4B,D). Thus, we examined the rescue phenotype in more
detail, after 9 h when Mgn expression appeared normal (Fig. S5).
Pax3 and Pax7 immunostaining showed that although the
dermomyotome was smaller, its epithelial nature was preserved in
somites injected with AM133 and purmorphamine (Fig. 5A-D).
Fig. 4. Pharmacological activation of Shh pathway or Gli3 KD restores myogenesis in the absence of miR-133 function. (A) Schematic overview of
the experimental approach. Posterior somites of HH14/15 embryos were injected with FITC-labelled antagomir-133 (AM133) with purmorphamine (Purm) or
FITC-labelled scrambled-antagomir (AMscr) with DMSO as control and the downstream analysis performed by in situ hybridization after 24 h incubation.
(B) In situ hybridization showed that Mgn expression was lost (white arrowheads) after AM133 with DMSO injection, n=8/8. Co-injection of AM133 with
purmorphamine, a synthetic agonist of the smoothened receptor, rescued myogenesis (black arrowheads). Mgn was expressed and the epithelial nature of
the dermomyotomewas preserved, but myotome size was reduced, n=14/14. Whole mount and sections are shown. (C) Schematic overview of the experimental
approach. Posterior somites of HH14/15 embryos were injected with FITC-labelled antagomir-133 (AM133) with Gli3 MO, electroporated and the downstream
analysis performed by in situ hybridization after 24 h incubation. (D) Co-transfection of AM133 with Gli3 MO rescued myogenesis (black arrowheads),
although myotome size was reduced (n=7/10). Whole mount and sections are shown. Area measurements were obtained using Fiji/ImageJ. ***P<0.001.
Fig. 5. Shh pathway activation in antagomir-133 injected somites restores dermomyotome morphology, epithelial organization and basement
membrane deposition but not proliferation. (A) Schematic overview of the experimental approach. Posterior somites of HH14/15 embryos were injected with
FITC-labelled antagomir-133 (AM133) with purmorphamine (Purm), and the downstream analysis was performed by immunostaining after 9 h incubation.
(B) Immunostaining for Pax3 or Pax7, AM133 and DAPI, and area measurements after AM133 with purmorphamine injections. (C) Immunostaining for pH3, AM133
and DAPI, and counting of positive cells after AM133 plus purmorphamine injections. The number of pH3-positive cells was reduced (white arrowhead) in AM133
plus purmorphamine-injected somites compared with somites from the contralateral side. (D) Epithelial organization and basement membrane deposition were
improved after co-injection of purmorphamine with AM133. Immunostaining for F-actin, laminin, AM133 and DAPI as indicated. Higher magnification images of
noninjected and injected somites are shown on the right, with the dermomyotome, dorsomedial lip andmore continuous BM staining beneath themyotome indicated
by white arrowheads. Scale bars: 50 μm. A minimum of ten sections from three embryos were analysed for each experiment. ***P<0.001.
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Fewer mitotic cells were detected by pH3 staining, compared with
contralateral somites (Fig. 5C), and this was similar to observations
in somites injected with AM133 alone (Fig. 2C). Actin and laminin
staining showed that epithelial character and BM deposition were
restored around the dermomyotome and myotome (Fig. 5D).
Finally, AM133 co-injection with purmorphamine restored
expression levels of DE hedgehog pathway genes (Fig. 6A).
Somites injected with AMscr, or with AM133 alone, or with
AM133 and purmorphamine, were examined using RT-qPCR.
Expression of Gli1, Gli2, Ptch1, Smo and Hhip was decreased in
somites injected with AM133, whereas expression of Gli3 increased,
consistent with the differential transcriptomics data. Purmorphamine
co-injection with AM133 led to recovery of Shh pathway components
compared with somites injected with AM133 alone. The exception
was Gli3 expression, which remained de-repressed. This was not
unexpected given that miR-133 function was still inhibited by
antagomir-133 (Fig. 6A). The relative expression of Pax3 and Pax7
increased, whilst that ofMyf5 andMgn decreased, after antagomir-133
injection.Myf5 was also significantly decreased after miR-133 KD in
the differential transcriptomics data (Fig. 3B). Co-injection of
purmorphamine with AM133 restored expression of pre-myogenic
markers, Pax3 and Pax7, to levels comparable to those of control
somites, and Myf5 and Mgn levels were also rescued (Fig. 6B). In
addition, expression of Snail1, a gene associated with epithelial
Fig. 6. Purmorphamine restores expression of Shh pathway and myogenic genes; however, Gli3 and cell cycle genes remain de-regulated in the
absence of miR-133 function. (A-D) RT-qPCR for Shh pathway components (A), myogenic genes (B), cell cycle genes (C) and a regulator of EMT and BMP
signalling (D), as indicated. White columns represent somites injected with scrambled antagomir (AMscr), black columns represent somites injected with
antagomir-133 (AM133), grey columns represent somites injected with AM133 with purmorphamine. (E) Summary of the regulatory interactions identified in this
study. DM, dermomyotome; FP, floor plate; MY, myotome; NC, notochord; NT, neural tube.
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mesenchymal transition (EMT), or gremlin 1 (Grem1), a BMP
antagonist was rescued by Shh pathway activation (Fig. 6D). However,
interestingly, genes associated with proliferation, Cdc20, Cdk1 and
Fgf8, remained repressed, consistentwith fewer pH3-positive cells and
smaller somites in the presence of AM133, irrespective of the presence
of purmorphamine. This suggests that myogenic differentiation and
epithelialization are uncoupled from proliferation and that there is
differential sensitivity of these processes for GliAct/GliRep balance.
Furthermore, there might be additional functions of miR-133,
independent of Gli3 targeting and Shh pathway regulation.
DISCUSSION
Despite recent progress, we still do not have a complete
understanding of how myogenic progenitor cells, once specified,
can stably execute their differentiation programme. miRNAs are
involved in the fine tuning of developmental processes, and we use
the accessibility of chicken embryos to investigate the function of
the miR-133 family in vivo, during embryonic myogenesis using
antagomir-mediated inhibition, differential transcriptomics and
rescue experiments.
Embryonic loss of function of miRNAs is often difficult to
investigate owing to functional redundancy of almost identical
mature miRNAs produced from multiple genetic loci, thus making
reverse genetic approaches in mice challenging. Observations from
mice with genetic deletion of miR-133a-1 and miR-133a-2 family
members suggest a role for adult skeletal muscle homeostasis (Liu
et al., 2011). By contrast, removal of the miR-206/133b cluster did
not reveal essential functions in skeletal muscle differentiation or
regeneration (Boettger et al., 2014). The concomitant knockout
(KO) of the miR-1-1/133a-2 and miR-1-2/133a-1 clusters, which
are expressed in cardiac and skeletal muscle, led to an early cardiac
defect (Wystub et al., 2013). However, an embryonic skeletal
muscle phenotype was not reported in any of these lines, most likely
due to expression from unaffected loci. Chick embryos offer the
opportunity to perform conditional miRNA KD experiments using
antagomirs that simultaneously inhibit the mature form of all miR-
133 family members produced (Goljanek-Whysall et al., 2014).
This has uncovered a crucial function of miR-133 in the modulation
of Shh signalling through direct targeting of Gli3, a transcriptional
repressor of the pathway and of myogenesis (McDermott et al.,
2005; Wen et al., 2010).
Shh signals, derived from the notochord and floorplate, activate
myogenesis in explants of presegmented mesoderm and act on
myogenic progenitors in the dermomyotome and dermomyotome
lip (Borycki et al., 1999, 1998; Münsterberg et al., 1995). This
induces expression of Myf5 via Gli activator proteins. Myf5
activates expression of miR-133 via upstream E-boxes (Rao et al.,
2006; Rosenberg et al., 2006; Sweetman et al., 2008), and we show
here that miR-133 directly targets Gli3 via a conserved site in the 3′
UTR (Fig. 3E). This site is conserved and was shown to be
functional in human Sertoli cells (Yao et al., 2016). We suggest a
model in which Gli3 silencing by miR-133 maintains the finely
tuned balance of Gli activator and repressor forms during
myogenesis (Fig. 3F). Thus, post-transcriptional silencing of Gli3
in nascent myoblasts promotes the stable activation of the skeletal
muscle differentiation programme in response to the Gli activators
Gli1 and Gli2 (Fig. 6E). This model is consistent with the finding
that concomitant Gli3 knockdown using a MO restored myogenic
differentiation after miR-133 KD (Fig. 4D). In addition, miR-133
expression, which is initiated by Myf5 in early myoblasts, is
mutually exclusivewith Gli3 (Fig. S1) (Berti et al., 2015; Mok et al.,
2015; Sweetman et al., 2008). In early somites, Gli3 transcripts are
excluded from Myf5/miR-133-expressing myoblasts and restricted
to the dermomyotome, including the dermomyotome lip (Fig. S1C).
In differentiating somites, in which the myogenic programme is
stably established, miR-133 and Gli3 remain expressed in a
mutually exclusive fashion, in the myotome or dermomyotome,
respectively (Goljanek-Whysall et al., 2014; Kahane et al., 2013). In
later-stage somites, AM133 injection had no effect on myogenin
expression (Fig. S2C), suggesting that miR-133 function is essential
specifically during early myogenesis. In addition, the lack of a
detectable phenotype at later stages shows that there are no
nonspecific, off-target or toxic effects.
De-repression of Gli3 transcript and protein following miR-133
KD led to inhibition of the Shh pathway (Figs 3B,D,F and 6A),
including the downregulation of Gli1 activator, which is important
for Myf5 activation (Gustafsson et al., 2002; McDermott et al.,
2005). Our results imply direct and indirect consequences resulting
from disruption of the Gli1/2 and Gli3 balance in early somites. It is
likely that early myoblasts are directly affected, with miR-133 KD
leading to loss of stable myogenesis, after initial expression of
MRFs (Fig. 1B). The finding that concomitant Gli3 KD, using
electroporation of aGli3MO (Fig. 4D, Fig. S3F), rescued myogenic
gene expression suggests that miR-133 mediated post-transcriptional
regulation of Gli3 is crucial to stably establish the myogenic
programme. However, myogenic differentiation also involves
extracellular matrix production and thus dermomyotome epithelial
organization could be affected indirectly.
Shh signal response genes expressed in the myotome include
Ptch1 and Ptch2 (Pearse et al., 2001), Gli1, Hhip (Kahane et al.,
2013), which attenuates signalling (Chuang and McMahon, 1999;
Ingham and McMahon, 2001), Fgf8 (Smith et al., 2005) and the
myogenic determination gene, Myf5 (Borycki et al., 1998;
McDermott et al., 2005). Differential transcriptomics and RT-
qPCR data showed that these genes are negatively affected by miR-
133 KD in developing somites (Figs 3B,D and 6A-C). Thus, they
are secondary targets of miR-133, but might be directly regulated by
Gli3 repressor (Fig. 3F). Using motif searches we found potential
Gli binding sites within 2 kb upstream of transcription start sites in
chicken Ptch1, Ptch2, Myf5 and Fgf8 genes, consistent with Ptch1
and Myf5 being direct targets for Gli proteins (Cohen et al., 2015;
Gustafsson et al., 2002).
Other genes downregulated after miR-133 inhibition, such as cell
cycle associated genes, Cdk1 and Cdc20, or sclerotome genes, Pax1
and Pax9 (Fig. 3B), are likely to be indirectly affected through
feedback mechanisms and/or noncell-autonomous mechanisms. For
example, the significant downregulation of Fgf8 could explain effects
on cell proliferation and growth aswell as on sclerotome differentiation
(Figs 3B and 6C). In addition, BMP signals cooperate with Shh to
activate somitic chondrogenesis (Murtaugh et al., 1999; Zeng et al.,
2002). BMP signalling is likely to be inhibited after miR-133 KD,
becauseGrem1, a BMP antagonist, is amongst the top 50 de-repressed
genes (Fig. 3B). This provides a possible explanation for negative
effects on Pax1 and Pax9 expression. Interestingly, in developing limb
buds, Gli3 specifies digit identities by promoting cell cycle exit and
BMP-dependent chondrogenic differentiation via controlling Grem1
expression (Lopez-Rios et al., 2012).
The role of Gli2 is less clear at present. Although we cannot
exclude that Gli2 also contributes to the negative regulation of Shh
pathway components, we think that this is less likely. Differential
transcriptomics showed that Gli2 was slightly de-repressed;
however, this change was not significant (Fig. 3D) and was not
confirmed by RT-qPCR (Fig. 6A), and the Gli2 3′UTR has no
predicted miR-133 target site. Expression patterns of Gli
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transcription factors in chick somites are more consistent with the
idea that Gli3 is the main repressor of the myogenic programme:
Gli1 and Gli2 are expressed in both dermomyotome and myotome;
however, Gli3 is excluded from the myotome (Borycki et al., 1998;
Kahane et al., 2013).
The effect of miR-133 KD on somite differentiation is dramatic.
Expression of myogenic differentiation genes and epithelial
organization of the dermomyotome and myotome are severely
affected (Figs 1 and 2, Fig. S2A,B). It has been shown that Shh is
important for laminin alpha 1 synthesis in the myotome (Anderson
et al., 2009), thus suggesting miR-133 KD, and the resulting Gli3
de-repression might lead to disrupted BM assembly, owing to
effects on laminin activation. Co-injection with purmorphamine
restored BM deposition, indicating that rescue of Gli1, and to some
extent Gli2, expression restores the balance of Gli proteins
sufficiently to allow laminin synthesis, even in the presence of
elevated Gli3 levels (Figs 4E and 5D).
Shh is also required to maintain the epithelial character of the
dermomyotome (Kahane et al., 2013), which was disrupted upon
miR-133 KD (Fig. 2C) and rescued by purmorphamine co-
injection with AM133 (Fig. 5D). Purmorphamine-mediated
rescue confirms that stabilization of the myogenic differentiation
programme is intimately linked with cellular organization, and
both depend on Shh pathway activity (Fig. 6E). This is in line with
the close integration of epithelial morphology and cell fate
determination mediated by Notch, GSK3β and Snail1 during
the initiation of myogenesis (Sieiro et al., 2016). On the other
hand, myogenesis and epithelialization were uncoupled from
proliferation. Proliferation was not rescued owing to the continued
de-repression of Gli3, which might affect expression of mitotic
signals, such as Fgf8, and cell cycle regulators, Cdc20 and Cdk1
(Fig. 6A,C). Similar observations have previously been made in
the limb (Lopez-Rios et al., 2012) and the neural tube (Cayuso
et al., 2006; Ulloa et al., 2007). Finally, it has been reported that
Shh causes premature myogenic differentiation (Borycki et al.,
1999; Kahane et al., 2001, 2013), which could also explain why
proliferation was not rescued.
Together, our data uncover a novel Shh/MRF/miR-133/Gli3 axis
by which miR-133 and its modulation of the Shh signalling pathway
via the direct targeting of Gli3 enable the coordination of epithelial
morphology with stabilization of the cellular differentiation
programme during early myogenesis.
MATERIALS AND METHODS
Somite injections
Fertilized eggs (Henry Stewart) were incubated until the desired stage of
development (Hamburger and Hamilton, 1951). Antagomir-133 (AM133)
and a scrambled sequence (AMscr), with final concentration of 1 µM, were
designed as previously described (Goljanek-Whysall et al., 2011). The
posterior six somites of HH14/15 embryos, or the equivalent interlimb-
level somites of HH20 embryos, were injected. Embryos were harvested
and processed for in situ hybridization or immunohistochemistry, or
injected somites were dissected and processed for RNA or protein
extraction. Purmorphamine (Sigma-Aldrich) was dissolved in dimethyl
sulfoxide (DMSO) (2 μM) (Dessaud et al., 2007) and co-injected with
antagomir. Gli3 antisense MO was 3′ FITC-labelled (Gene Tools)
(Table S1). Gli3 MO was co-injected with AM133 into the posterior six
somites of HH14/15 embryos, followed by electroporation using six 10-ms
pulses of 60 V.
In situ hybridization, immunohistochemistry and image analysis
Whole-mount in situ hybridization using digoxigenin-labelled LNA oligo
probe for miR-133a (Exiqon) or antisense RNA probes for Pax3, Myf5,
MyoD, Mgn, Gli3 (a gift from Matt Towers, University of Sheffield,
Sheffield, UK) was carried out as described previously (Goljanek-Whysall
et al., 2011). Antagomirs were detected using anti-FITC antibody coupled to
alkaline phosphatase (Roche) as previously described (Goljanek-Whysall
et al., 2011). Cryosections (15 μm) of 4% paraformaldehyde-fixed OCT
embedded embryos were immunostained. Primary antibodies used were
anti-Pax3 (1:200), anti-Pax7 (1:200), anti-laminin (1:100), from the
Developmental Studies Hybridoma Bank, and anti-rabbit pH3 (1 mg/ml,
Merck). Phalloidin (Invitrogen) was used at 1:100 to stain actin. Secondary
antibodies were Alexa Fluor 647-conjugated anti-rabbit or anti-mouse
(Invitrogen), used at 1 mg/ml in 5% bovine serum albumin/5% goat serum/
PBS. DAPI (Sigma-Aldrich) was used at 0.1 mg/ml in PBS. Sections were
visualized on an Axioscope with Axiovision software (Zeiss). Images were
imported into Fiji/ImageJ, and areas of staining were calculated from binary
images by calculating pixel numbers from injected and noninjected sides,
when appropriate neural tube staining was removed. A minimum of 10
sections from three embryos were analysed for each experiment. Statistical
analysis used GraphPad Prism (version 6) software. Mann–Whitney
nonparametric two-tail testing was applied to determine P-values.
RNA extraction and RT-qPCR
RNA and miRNA isolation from somites was performed using RNeasy
(Qiagen) and miRCURY RNA kits (Exiqon) according to the manufacturer’s
protocols. cDNA was synthesized from 600 ng RNA using a Maxima First
Strand cDNA synthesis kit (Thermo Fisher Scientific). For miRNAs, cDNA
was synthesized from 10 ng using Universal cDNA synthesis kit II (Exiqon).
RT-qPCR was performed on a 7500 Fast Real Time PCR machine (Applied
Biosystems) using SYBRGreen PCRMaster Mix (Thermo Fisher Scientific)
according to the manufacturer’s instructions. Primers for the miR-133a
sequence 5′-UUGGUCCCCUUCAACCAGCUGU-3′, were designed by
Exiqon. Other primers (Sigma-Aldrich) (Table S1) were designed with
Primer3 software (http://biotools.umassmed.edu/bioapps/primer3_www.cgi).
RT-qPCR was normalized to Gapdh for mRNA, or Rnu6 for miRNA, based
on Exiqon protocols. Three independent experiments eachwith three replicate
samples were performed for each RT-qPCR. The ΔΔCT (Livak and
Schmittgen, 2001) method was used to analyse gene expression levels.
Statistical analysis was performed as previously described.
RNA sequencing
Sequencing libraries were built according to Illumina Standard Protocols
(Earlham Institute). Each sample contained pooled, injected somites from
ten embryos. Sequencing was performed on one lane of a flow cell on an
Illumina HiSeq2500 platform. cDNAwas end-paired, A-tailed and adapter-
ligated before amplification and size selection. Library QC used a gel and a
bioanalyser. Transcript abundances for each sample were estimated with
Kallisto (Bray et al., 2016) using the Gallus gallus reference cDNA set
(Galgal5) downloaded from Ensembl (Yates et al., 2016). Differential
expression between antagomir-133 (AM133)- and scrambled (AMscr)-
injected samples was calculated using DESeq (Anders and Huber, 2010),
with an adjusted P-value significance threshold of 0.05. The data have been
uploaded to the NCBI SRA, under accession number PRJNA384007. GO
term analysis was performed using the DAVID Bioinformatics Resources
6.8, available at https://david.ncifcrf.gov/. Statistical analysis was performed
using false discovery rate (FDR).
DNA constructs, transfections and luciferase assay
Sensor constructs contained a chick Gli3 3′UTR fragment in a modified
pGL3 vector (Promega); for primers see Table S1. Mutant construct
replaced the miR-133a seed site GGGACCA with the sequence
GTTGACAA. Chick dermal fibroblast (DF1) cells were transfected in
96-well plates with 200 ng luciferase reporter plasmid with miR-133 or
control (50 nM, Sigma-Aldrich) using Lipofectamine 2000 (Invitrogen).
A Renilla luciferase plasmid was included to normalize for transfection
efficiency and transfections used triplicate samples. The miRNA mimics
were identical to mature miRNA; sequences are listed in Table S1. Firefly
and Renilla luciferase activity was measured after 24 h using a multilabel
counter (Promega GloMax), and relative activity was calculated for
each sample.
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Primary cell culture and western blotting
Somites of wild-type embryos were dissected and cultured in Dulbecco’s
modified Eagle medium, 10% fetal bovine serum, 1% penicillin/
streptomycin for 4 h before being transfected with Gli3 MO (1 mM) or
control MO (1 mM) using Endoporter PEG (Gene Tools) and protein
extracted after 48 h. Somites from AM133- or AMscr-injected embryos
were dissected for protein extraction. Protein lysate (31.5 μg) was run on
pre-cast 4-15% polyacrylamide gels (Bio-Rad) and blotted onto
polyvinylidene fluoride membrane (Bio-Rad). Primary antibody against
Gli3 (1:200, 6F5 Gli3N, Genentech, Wen et al., 2010) was applied at 4°C
overnight before secondary polyclonal goat anti-mouse HRP (1:1000,
P0447, DAKO) was applied for 1 h at room temperature. The blots were
treated with an ECL substrate kit (GE Healthcare) and imaged. Primary
antibody against actin (1:1000, ab3280, Abcam) was applied at 4°C
overnight; secondary polyclonal goat anti-mouse HRPwas applied for 1 h at
room temperature. The blots were treated with an ECL substrate kit and
imaged. Quantification of blots was performed using ImageJ.
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